Acadia Pharmaceuticals Inc
ACAD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001070494
In the last 90 days, Acadia Pharmaceuticals Inc insiders filed 0 open-market purchases and 1 sale; 354 institutions reported holding it in 13F filings for Q2 2026, worth $4.27B in total; no superinvestor holds it.
Holders of 5% or more of ACAD
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Acadia Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 13D/A | 25.40%43.3M shares | – | Jan 17, 20233 filings | Feb 26, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 11.90%19.9M shares | – | Feb 7, 20251 filing | Feb 7, 2025 | SEC |
| Vanguard Portfolio Management LLC | 13G | 5.15%8.78M shares | New | Apr 28, 20261 filing | Apr 28, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
26 Schedule 13D and 13G filings on Acadia Pharmaceuticals Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 20266:17 AM ET | State Street Corp | 13G | 4.40%7.65M shares | −0.90 ppfrom 5.30%Below 5% | Sep 30, 2026 | SEC |
| Aug 7, 20268:21 AM ET | State Street Corp | 13G | 5.30%9.08M shares | New | Jun 30, 2026 | SEC |
| Apr 28, 20263:53 PM ET | Vanguard Portfolio Management LLC | 13G | 5.15%8.78M shares | New | Mar 31, 2026 | SEC |
| Mar 26, 20263:06 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Feb 26, 20266:59 PM ET | Baker Bros. Advisors LPand 4 others | 13D/A | 25.40%43.3M shares | – | Feb 24, 2026 | SEC |
| Nov 14, 20258:16 AM ET | RTW Investments, LPand 1 other | 13G/A | 4.20%7.14M shares | −1.00 ppfrom 5.20%Below 5% | Sep 30, 2025 | SEC |
| Feb 14, 20259:00 AM ET | RTW Investments, LPand 1 other | 13G/A | 5.20%8.71M shares | – | Dec 31, 2024 | SEC |
| Feb 7, 20256:04 AM ET | BlackRock, Inc. | 13G/A | 11.90%19.9M shares | – | Jan 31, 2025 | SEC |
| Nov 14, 2024 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | RTW Investments, LP | 13GOld format | – | New | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 26, 20245:25 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| May 24, 2023 | Baker Bros. Advisors LP | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Price T Rowe Associates Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 31, 20235:52 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 17, 2023 | Baker Bros. Advisors LP | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Price T Rowe Associates Inc | 13GOld format | – | – | – | SEC |
| Feb 9, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 4, 20224:12 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Price T Rowe Associates Inc | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
16 notices from officers, directors and other affiliates planning to sell Acadia Pharmaceuticals Inc shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Aug 5, 20264:49 PM ET | Schneyer Mark C.Officer | 5.85K | $158.8K | Aug 5, 202610b5-1 | Piper Sandler & Co Inc | SEC |
| Jun 26, 20263:09 PM ET | Kihara JamesOfficer | 11.4K | $297.0K | Jun 26, 202610b5-1 | Piper Sandler & Co Inc | SEC |
| May 26, 20264:02 PM ET | James K KiharaOfficer | 5.40K | $114.4K | May 26, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 10, 20255:59 PM ET | James M DalyDirector | 30.0K | $671.0K | Nov 10, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 18, 20254:31 PM ET | Schneyer Mark C.Officer | 22.0K | $557.3K | Aug 18, 202510b5-1 | Piper Sandler & Co Inc | SEC |
| Jun 4, 20254:35 PM ET | Laura BregeDirector | 14.4K | $314.6K | Jun 4, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 16, 20255:10 PM ET | Schneyer Mark C.Officer | 2.00K | $35.2K | May 16, 202510b5-1 | Piper Sandler & Co Inc | SEC |
| May 16, 20255:06 PM ET | Kihara JamesOfficer | 4.00K | $70.4K | May 16, 202510b5-1 | Piper Sandler & Co | SEC |
| Mar 6, 202512:17 PM ET | Garofalo Elizabeth A.Director | 4.92K | $89.7K | Mar 5, 2025 | MORGAN STANLEY SMITH BARNEY LLC EXECUTIVE SERVICES | SEC |
| Dec 15, 202312:46 PM ET | Kihara JamesOfficer | 2.00K | $56.1K | Dec 15, 2023 | Piper Sandler & Co. | SEC |
| Sep 15, 20231:06 PM ET | Kihara JamesOfficer | 2.00K | $51.7K | Sep 15, 202310b5-1 | Piper Sandler & Co | SEC |
| Aug 21, 202311:15 AM ET | Schneyer Mark C.Officer | 10.0K | $293.3K | Aug 21, 202310b5-1 | Piper Sandler & Co. | SEC |
| Jul 14, 202311:33 AM ET | Davis StephenOfficer · Director | 100.0K | $2.58M | Jul 14, 202310b5-1 | Piper Sandler & Co. | SEC |
| Jul 13, 202310:42 AM ET | Davis StephenOfficer · Director | 71.6K | $1.77M | Jul 11, 202310b5-1 | Piper Sandler & Co. | SEC |
| Jun 15, 202311:36 AM ET | Kihara JamesOfficer | 2.00K | $48.3K | Jun 15, 202310b5-1 | Piper Sandler & Co. | SEC |
| Jun 12, 20232:34 PM ET | Brege LauraDirector | 4.50K | $112.2K | Jun 12, 202310b5-1 | Piper Sandler & Co. | SEC |